Align Technology's request for a temporary injunction against Angelalign Technology Inc.'s patent was rejected; Dehan Dental received tens of millions of dollars in strategic investment; 3D …

Angelalign Technology Inc.'s Six-City Early Orthodontic Intervention Lecture Tour Attracts Over 3,000 Dentists, Chinese and International Experts Explore the Window for Children's Orthodontic Intervention

In April 2026, Angelalign Technology Inc.'s "Scientific Early Orthodontic Intervention, Strategic Approaches" academic conferences were successively held in six cities: Suzhou, Luoyang, Guangzhou, Wuhan, Hangzhou, and Kunming, attracting over 3,000 dental professionals in total.

The conferences invited overseas orthodontic experts from New Zealand, Brazil, and other countries, alongside leading domestic scholars and frontline clinicians, to discuss two main topics: "Orthodontic expansion and Jaw growth and development" and "Precise Full-Cycle Intervention During the Growth and Development Period." Experts pointed out that expansion strategies should return to individual developmental characteristics. During the critical window period of ages 6 to 12, intervention should follow the three-dimensional principle of "prioritizing width coordination, emphasizing vertical control, and achieving length improvement as a result."

As one of the earliest brands in China to focus on early orthodontic intervention for children, Angelalign Technology Inc. continues to increase investment in product innovation, clinical research, and professional training, building a comprehensive early orthodontic intervention solution system covering different growth and development stages.

Dentsply Sirona's 2026 China Prosthodontics Lecture Tour Kicks Off in May

In late May 2026, Dentsply Sirona invited Italian dental restoration and micro-aesthetic expert Dr. Marco Martignoni to return to China for a prosthodontics lecture tour titled "Ultimate Restoration, The Beauty of the Final Result" in three cities: Beijing (May 25), Chengdu (May 27), and Shanghai (May 29).

This lecture tour will center on the core concept of "root-crown integration," demonstrating solutions for common pain points in posterior functional restoration and anterior aesthetic restoration through real clinical cases. It will also focus on how chairside immediate restoration can achieve efficient and stable restorative outcomes within a single visit.

Professor Marco has served as President of the European Society of Endodontology (ESE) and the Italian Society of Endodontics. He is also the founder of the Italian Society of Microdentistry, an honorary member of the French Society of Endodontics, and the founder of SIPRO (Italian Society of Prosthodontics and Oral Rehabilitation). He currently serves as a visiting professor for the International Master's program in Endodontics and Restorative Dentistry at the University of Siena. His expertise focuses on endodontic treatment and dental restoration, and he conducts lectures and practical seminars globally.

Align Technology's Request for Preliminary Injunction Denied, Normal Operation of Angelalign Technology Inc.'s A7 Solution in the European Market Unaffected

On May 12, 2026, the Düsseldorf division of the Unified Patent Court issued a ruling dismissing the request for a preliminary injunction filed by Align Technology, Inc. against Angelalign Technology Inc. The court rejected Align Technology's request to prevent Angelalign Technology Inc. from using its "A7 Premolar Extraction Solution" in the European market. The normal operation of Angelalign Technology Inc.'s A7 solution in the European market remains unaffected. The court determined that all evidence submitted by Align Technology came from promotional materials such as official website screenshots, product manuals, and webinars, without any experimental mechanical evaluation of specific aligners. The court stated that the "argument was based solely on assumptions and speculation," and the plaintiff's infringement claims did not meet the evidentiary standard required for a preliminary injunction, leading to the dismissal of the request.

Official Announcement | The 30th Sino-Dental Opens in June, DENTALGOODNEWS (Leading Dental Industry Media, DGN) Becomes Official Media Partner

From June 9 to 12, 2026, the 30th Sino-Dental will be held at the China National Convention Center in Beijing. This exhibition is co-hosted by the International Exchange and Cooperation Center, National Health Commission of the P. R. China and the Chinese Stomatological Association (CSA), with support from the Peking University School and Hospital of Stomatology.

This year, DGN has officially become the official media partner for this exhibition. DGN will launch a series of original content during the event, including pre-exhibition guides and preview reports, exclusive first-hand reports during the exhibition, continuous on-site news flashes, and in-depth post-exhibition analysis of industry trends. This aims to connect global voices and promote broader attention and citation of Chinese oral industry products, technologies, and research on international platforms.

3D Systems Q1 2026: Dental Business Revenue Up Over 20% Year-over-Year, Driven by Monolithic Denture Printing System

On May 11, 2026, 3D Systems released its Q1 2026 financial results. Dental business revenue was $50.1 million, an increase of approximately 21% year-over-year, primarily driven by the monolithic denture printing system. Adjusted EBITDA turned profitable at $2.1 million. Cash and cash equivalents stood at $85.1 million. The company expects Q2 revenue between $93 million and $95 million, with an Adjusted EBITDA loss projected between $2 million and $4 million.

KTJ MEDICAL TECHNOLOGY CO., LTD. (Short for KTJ) 2025 Annual Report: Revenue of 490 Million RMB, Up 4.18%; Implant Prosthesis and Components Segment Revenue Down 12%

On April 29, 2026, KTJ released its 2025 annual report. Full-year operating revenue was 490 million RMB, a year-over-year increase of 4.18%. Overseas sales revenue was 133 million RMB, up 61.46%, accounting for 27.32% of total revenue. Domestic sales revenue was 355 million RMB, down 8.10%. Revenue from the implant prosthesis and components business was 132 million RMB, a year-over-year decrease of 12.24%. R&D expenses were 20.4333 million RMB, with an R&D intensity of 4.17%. Net profit was 31.268 million RMB, a decrease of 38.62%. Credit impairment losses were 24.9508 million RMB. The company has submitted IPO Guidance Filing materials to the Beijing Stock Exchange (BSE) and is currently in the guidance period.

US Dental DSO Listed Company Q1 2026: Net Profit Turns to Loss, Equity Incentives Cause Significant Increase in Service Costs

On May 13, 2026, Park Dental Partners, Inc. (NASDAQ: PARK) released its Q1 2026 financial results. Revenue was $62.695 million, a year-over-year increase of 6.22%. The company recorded a stock-based compensation expense of $4.024 million for the first time, resulting in a net loss of $0.39 million. Patient visits totaled 178,527, across its 86 clinics and 221 dentists. The company maintains its full-year guidance for same-store revenue growth of 3.5% to 5%, excluding the impact of future acquisitions or new clinic openings that have not yet been completed.

Dehan Dental Receives Multi-Million Dollar Strategic Investment for AI Big Data R&D, Talent Development, and National Chain Expansion

A report from the Qiaokou District Converged Media Center indicates that Dehan Dental has received an additional multi-million dollar strategic investment from OrbiMed, with Hubei Guanghui Tongdao Capital also participating. The funds will be directed towards AI big data R&D and application, high-end talent development, and the expansion of its national chain of clinics. An official announcement from Dehan Dental states that the company held an IPO launch conference on December 30, 2025, and announced the initiation of its plan for a main board listing on the Hong Kong Exchanges and Clearing Limited (HKEX).

Huachi Dental Clinic Plans to Invest Up to 90 Million RMB of Idle Funds in Bank Wealth Management Products

On April 27, 2026, Huachi Dental Clinic announced its intention to use up to 90 million RMB of its own idle funds to purchase low-risk bank wealth management products with a one-year term. The maximum amount is 90 million RMB, all sourced from the company's idle funds. This investment does not constitute a related party transaction. It will be approved by the General Manager and executed by the finance department, with a validity period of one year from the date of approval by the 2025 shareholders' meeting. The company will assign financial personnel for continuous tracking and enhanced supervision. The proposal has been approved by the Board of Directors and the Board of Supervisors but still requires approval from the shareholders' meeting.

Dental Laboratory Consolidator SDL Acquires BRLIT, Annualized Revenue Base Increases Over 375%

On May 6, 2026, Standard Dental Labs Inc. (SDL), a consolidator of dental laboratories, completed the acquisition of BRLIT Dental Laboratory in Florida. This acquisition increased the annualized revenue base from approximately $236,000 to over $1.1 million, an increase of more than 375%. Founded in 1977, BRLIT offers a full range of services including dental crowns, bridges, and implant restorations. It will continue to operate under the SDL platform post-acquisition, with key personnel retained. SDL CEO James Brooks stated that this move validates and accelerates the company's scaling efforts. The company previously filed a Form 1-A/A with the SEC in July 2025 to raise funds to support M&A and operational growth.

National Healthcare Security Administration (NHSA) Releases Five-Year Plan: Achieve Full Coverage of On-Site Inspections at Designated Institutions by 2030

On May 13, 2026, the National Healthcare Security Administration (NHSA) released the "Five-Year Action Plan for Medical Insurance Fund Supervision and Inspection (2026-2030)." The plan aims to achieve full coverage of on-site inspections at all designated medical institutions nationwide by 2030, with a focus on covering various types of institutions, including specialized dental hospitals. It will also build a regulatory model using big data and artificial intelligence. The plan simultaneously establishes a credit management mechanism that balances incentives and constraints, where credit evaluation results will be linked to inspection frequency and Medical Insurance Fund payments.

Seven Departments Jointly Issue "Pharmaceutical Representative Management Measures," Clarifying Nine Prohibitions

On May 7, 2026, the National Medical Products Administration and six other ministries jointly issued the "Pharmaceutical Representative Management Measures," effective from August 1, 2026, repealing the "Pharmaceutical Representative Record Management Measures (Trial)." The measures clearly define nine prohibitions for pharmaceutical representatives, including bans on unregistered promotion and offering kickbacks, and five prohibited behaviors for medical institutions, such as accepting kickbacks or donations. A separate regulatory document for Medical Devices companies will be formulated subsequently.

Indian B2B2C Dental Products Company Laxmi Dental Launches AI-Powered Remote Dental Monitoring Platform, Claims 30%-50% Reduction in Follow-Up Visits

On May 12, 2026, Laxmi Dental launched the iScope360 AI-powered remote dental monitoring platform in Mumbai. The platform is claimed to reduce the number of in-person follow-up visits by 30% to 50% and improve treatment compliance by approximately 20% to 30%. The platform consists of three modules: iTrack, iHealth, and iTrack Live, allowing patients to upload data via their smartphones for remote monitoring. The company was listed on the Indian NSE and BSE in January 2025, with its opening day share price rising 27% above the issue price.

Antitrust Lawsuit Escalates: Dentists in Four US States File Class Action Against Delta Dental

On April 30, 2026, dental providers in California, Wisconsin, Michigan, and Massachusetts filed a class-action lawsuit against Delta Dental in state courts. The lawsuit alleges that Delta Dental holds over 50% market share in these states and uses non-compete agreements to suppress dentist compensation. The plaintiffs seek an injunction to stop the anti-competitive practices and demand treble damages. Delta Dental was recently fined $2.25 million in an administrative penalty for concealing a Data Breach in North Carolina.

Dental Insurer Delta Dental Fined $2.25 Million for Concealing Data Breach and Improperly Retaining Information

On April 30, 2026, the New York State Department of Financial Services announced that Delta Dental Insurance Company and its New York subsidiary were fined $2.25 million for a breach involving approximately 60,000 files due to the 2023 MOVEit vulnerability. The company was also prohibited from applying for tax credits or insurance claims. The company confirmed the breach on July 6, 2023, but did not report it to regulators until December 15, far exceeding the 72-hour requirement. Consumers were notified in March 2024, and a settlement concluded the regulatory investigation.

Illegal Gains of 20 RMB Result in a Fine of 25,000 RMB: A Dental Clinic Fined for Illegally Purchasing Drugs and Using Expired Medical Devices

On March 26, 2026, the Wangcang County Market Supervision Administration issued an administrative penalty decision (Wang Shi Jian Chu Fa [2026] No. 31) against a dental clinic in Wangcang County. The clinic was found to have violated regulations by purchasing drugs from enterprises without drug distribution qualifications and using expired Medical Devices. The clinic was ordered to rectify these issues. The penalty included a warning, confiscation of the relevant drugs and Medical Devices and illegal gains of 20 RMB, and a fine of 25,000 RMB.

New Study: Maternal Antibodies Can "Program" Offspring's Oral Immunity, Potentially Influencing Periodontitis Risk

In April 2026, a research team led by Avi-Hai Hovav from the Hebrew University-Hadassah Faculty of Dental Medicine in Jerusalem published a study in "Nature Communications." The study found that maternal IgG, transmitted via the placenta and breast milk, can program oral immunity in early life in mice, inducing tolerance and promoting epithelial barrier sealing. This could potentially reduce the risk of periodontitis in adulthood. Pups lacking these antibodies showed immune hyperactivation and bone loss. The researchers cautioned that the conclusions are based solely on a mouse model and that human applications require long-term follow-up validation.